ALS Drug Development: Reflections from the Past and a Way Forward
β Scribed by Swati Aggarwal; Merit Cudkowicz
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 246 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1933-7213
No coin nor oath required. For personal study only.
β¦ Synopsis
Tremendous advances in our understanding of pathogenesis of amyotrophic lateral sclerosis (ALS) have provided a rich pipeline of drugs for clinical trialists. At least 32 unique compounds have been tested. Nevertheless, riluzole is currently the only treatment that prolongs survival. We present a critical overview of past clinical trials, how therapies are selected for testing in people, challenges with ALS clinical trial design and conduct, and ways to best move forward.
π SIMILAR VOLUMES
Sustainable development is hard to achieve, especially if the target is food security in drought-prone, economically and ecologically marginal pastoral areas such as the Turkana District in Kenya. A brief historical account is given of the famine relief and development efforts in the area and their
Drawing on South African experiences, this paper provides a critical evaluation of the World Bank's 1997 World Development Report, `The State in a Changing World'. The paper sets out the Bank's conception of a `good' state as it emerges from the Report. We then evaluate this conception of the state